← Back to Search

Behavioral Intervention

MEMI App for Traumatic Brain Injury

N/A
Waitlist Available
Led By Emily Morrow, Ph.D.
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Must not have
For non-injured comparison peers: History of neurological or cognitive disability, including TBI
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week in each intervention condition
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a mobile phone app called MEMI that aims to help adults with chronic traumatic brain injury improve their memory. The study will look at whether the app is easy to use and helpful,

Who is the study for?
This trial is for adults with chronic traumatic brain injury who struggle with memory issues. It aims to test a mobile phone-delivered memory support tool called MEMI. Participants should be comfortable using a smartphone and have a history of memory problems due to their condition.
What is being tested?
The study is testing the effectiveness of MEMI, an app designed to help people with traumatic brain injury improve their memory through spaced retrieval exercises. The pilot will assess how easy it is to use the app and whether it's well-received by users.
What are the potential side effects?
Since this intervention involves using a mobile application for improving memory, there are no direct physical side effects expected from participating in this trial.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a history of brain injury or cognitive disability.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week in each intervention condition
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week in each intervention condition for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Feasibility (Engagement)
Secondary study objectives
Cued Recall of Word Forms
Cued Recall of Word Meanings
Free Recall of Word Forms
Other study objectives
Number of Spatial Contexts

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Intervention, then Active ComparatorExperimental Treatment2 Interventions
Participants complete the Intervention (MEMI spaced retrieval) week, followed by the Active Comparator (blocked retrieval) week.
Group II: Active Comparator, then InterventionExperimental Treatment2 Interventions
Participants complete the Active Comparator (blocked retrieval) week, followed by the Intervention (MEMI spaced retrieval) week.

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
902 Previous Clinical Trials
938,780 Total Patients Enrolled
Emily Morrow, Ph.D.Principal InvestigatorVanderbilt University Medical Center
~5 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top